February 2025 Psychedelic Patent Update: Terran Secures New Overlapping IP; Porta Sophia Becomes USPTO Information Source Post published:March 27, 2025 Post category:Psychedelic Patent Analysis/Pα+
Pα+ Psychedelic Bulletin #191: Psychedelics at SXSW; Swiss Study Finds No Impact of Psilocybin on Alcohol Use Disorder Post published:March 17, 2025 Post category:Psychedelic Bulletin/Pα+
Behind the Scenes of the “Psychedelic Renaissance” at SXSW 2025 Post published:March 14, 2025 Post category:Analysis/News/Pα+
Inside the World’s Most Active Psychedelic Therapy Site: A Conversation with Sunstone Therapies Post published:March 12, 2025 Post category:Interviews/Pα+
Pα+ Psychedelic Bulletin #190: ‘Europe’s Most Feared Investor’ Teams Up with Musk Associate to Fund Lykos Therapeutics Post published:March 6, 2025 Post category:Psychedelic Bulletin/Pα+
Pα+ Psychedelic Bulletin #189: Psychedelic Philanthropists Weigh In on New Administration; Washington Lawmakers, Experts, Residents Debate Psychedelics Bills; Compass and GH Share Updates Post published:February 28, 2025 Post category:Psychedelic Bulletin/Pα+
Psychedelic Policy Push Continues: Over 60 Bills Introduced Across 22 States Post published:February 27, 2025 Post category:Analysis/News/Pα+
January 2025 Psychedelic Patent Update: Lykos’ New Continuation Applications; Ambio Files on Ibogaine & Magnesium Post published:February 25, 2025 Post category:Psychedelic Patent Analysis/Pα+
MDMA for Active-Duty Troops: Aaron Wolfgang on DoD’s Unprecedented Study Post published:February 19, 2025 Post category:Interviews/Pα+
Pα+ Psychedelic Bulletin #188: Q4’24 Lobbying Update; Virginia Lawmakers Question Purpose, Precedent of Compass Bill; VA Loses Psychedelics Champion; GH Discusses Lack of Placebo Effect Post published:February 14, 2025 Post category:Psychedelic Bulletin/Pα+